Breast cancer is a very common malignancy among women. Although there are well-developed clinical guidelines, guideline updates may be required to account for the range of driver alterations now recognized in this indication.1-3
Identify actionable targets for molecularly-guided therapy across all breast cancer subtypes.4,5
Improve prognostication and identify patients at high risk of resistance to certain therapies.5,6
Support disease monitoring and targeted therapy allocation through liquid biopsies, with applications for both ctDNA detection and sequencing.7-9
Develop, customize, and control your own workflow
Get access to comprehensive genomic profiling
Choose the panels that suit you best
Comprehensive genomic profiling and clinical interpretation
Structured molecular insights report with therapy options
Use of validated lab without own investments or resources
Match your workflow to your objectives and deliver precise and consistent results. Our products enable you to capture challenging tumor samples, and extract more clinically relevant information from every sample, while minimizing user intervention and extraction-to-extraction variability.
Foundation Medicine connects physicians, patients, and biopharma partners to the latest insights in cancer care. This world-leading molecular insights company offers a proven portfolio of tests and services that help guide treatment strategies for all of your advanced cancer patients.
Would you like to know more about our integrated solutions, or do you have other questions? Leave your details and we will get in touch with you.
Matthias Bodmer
Disease Area Manager Oncology
